Correlation Between Sensei Biotherapeutics and DiaMedica Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sensei Biotherapeutics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sensei Biotherapeutics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sensei Biotherapeutics and DiaMedica Therapeutics, you can compare the effects of market volatilities on Sensei Biotherapeutics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sensei Biotherapeutics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sensei Biotherapeutics and DiaMedica Therapeutics.

Diversification Opportunities for Sensei Biotherapeutics and DiaMedica Therapeutics

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Sensei and DiaMedica is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Sensei Biotherapeutics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Sensei Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sensei Biotherapeutics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Sensei Biotherapeutics i.e., Sensei Biotherapeutics and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Sensei Biotherapeutics and DiaMedica Therapeutics

Given the investment horizon of 90 days Sensei Biotherapeutics is expected to under-perform the DiaMedica Therapeutics. In addition to that, Sensei Biotherapeutics is 1.49 times more volatile than DiaMedica Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.23 per unit of volatility. If you would invest  423.00  in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of  93.00  from holding DiaMedica Therapeutics or generate 21.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sensei Biotherapeutics  vs.  DiaMedica Therapeutics

 Performance 
       Timeline  
Sensei Biotherapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sensei Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Sensei Biotherapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
DiaMedica Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Sensei Biotherapeutics and DiaMedica Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sensei Biotherapeutics and DiaMedica Therapeutics

The main advantage of trading using opposite Sensei Biotherapeutics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sensei Biotherapeutics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.
The idea behind Sensei Biotherapeutics and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences